Pershing Square Sohn Cancer Research Alliance


The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.

Early-Stage Funding for Cancer Research

The Prize for young investigators provides early-stage funding opportunities to New York scientists with innovative ideas in cancer research. The program surrounding the Prize is a catalyst in bridging the gap between the academic scientific community and the business community.

LEARN MORE2018 PRIZE WINNERS

2018 Prize Winners

News

May 9, 2019
THE TISCH CANCER INSTITUTE AND PRECISION IMMUNOLOGY INSTITUTE AT MOUNT SINAI LAUNCH CENTER FOR COMPUTATIONAL IMMUNOLOGY

Newswise — The Tisch Cancer Institute and the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai have launched the Center for Computational Immunology, a hub that will help researchers studying cancer, genomics, machine learning, and immunology collaborate to find better targeted immunotherapies for patients. Benjamin Greenbaum, PhD, Assistant Professor of Oncological Sciences, Pathology, and Medicine (Hematology and Medical Oncology), will serve as Director.

READ MORE

Events

October 23, 2018 
SECOND ANNUAL PERSHING SQUARE SOHN RETREAT

On Tuesday, October 23rd, 2018, the Pershing Square Sohn Cancer Research Alliance held its Second Annual Pershing Square Sohn Retreat in Nicholls-Biondi Hall at Cold Spring Harbor Laboratory in Long Island. The Retreat gave the 2015 Pershing Square Sohn Prize winners, who had just finished their final year of funding, the chance to present their work performed over the past three years to their peers and mentors.

READ MORE

“The Pershing Square Foundation is proud to support scientific leaders in the fight against cancer.”

Bill Ackman, Co-Founder. The Pershing Square Foundation